Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype by Xuejiao Yin, Xuelian Hu, Hongyan Tong, Liangshun You

Get full text

Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells by Liangshun You, Liangshun You, Liangshun You, Qingmei Han, Qingmei Han, Li Zhu, Yijing Zhu, Changqian Bao, Changqian Bao, Chunmei Yang, Chunmei Yang, Chunmei Yang, Wen Lei, Wen Lei, Wen Lei, Wenbin Qian, Wenbin Qian, Wenbin Qian

Get full text

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection by Qingqing Lin, Li Zhu, Zuowei Ni, Haitao Meng, Liangshun You

Get full text

Gut Microbiome and Metabolome Were Altered and Strongly Associated With Platelet Count in Adult Patients With Primary Immune Thrombocytopenia by Xuewu Zhang, Xuewu Zhang, Xuewu Zhang, Silan Gu, Liangshun You, Liangshun You, Liangshun You, Yu Xu, Yu Xu, Yu Xu, De Zhou, De Zhou, De Zhou, Yunbo Chen, Ren Yan, Huiyong Jiang, Yating Li, Longxian Lv, Wenbin Qian, Wenbin Qian

Get full text

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting by Xuejiao Yin, Yi Liu, Jianai Sun, Hongyan Tong, Haitao Meng, Liangshun You

Get full text

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting by Shenhe Jin, Yi Liu, Ye Zhang, Fengping Zhou, Liangshun You, Jin Zhang

Get full text

Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 by Qingqing Lin, Qingqing Lin, Liping Mao, Liping Mao, Li Shao, Li Shao, Li Zhu, Li Zhu, Qingmei Han, Qingmei Han, Honghu Zhu, Honghu Zhu, Jie Jin, Jie Jin, Liangshun You, Liangshun You

Get full text

The mechanisms and cross-protection of trained innate immunity by Shiwei Hu, Danhong Xiang, Xinlu Zhang, Lan Zhang, Shengjie Wang, Keyi Jin, Liangshun You, Jian Huang

Get full text

Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy by Min Yang, Yu Chen, Li Zhu, Liangshun You, Hongyan Tong, Haitao Meng, Jianpeng Sheng, Jie Jin

Get full text

The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses by Liangshun You, Liping Mao, Juying Wei, Shenhe Jin, Chunmei Yang, Hui Liu, Li Zhu, Wenbin Qian

Get full text

When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China by Yi Liu, Xuejiao Yin, Dan Xu, Yunfei Lv, Li Zhu, Min Yang, Qiumei Yao, Jie Jin, Li Huang, Haitao Meng, Liangshun You

Get full text

First case of acute promyelocytic leukemia with TFG-RARA achieved complete remission treated with venetoclax and all-trans retinoic acid by Li Zhu, Ting Shi, Yi Liu, Shuqi Zhao, Huanping Wang, Zhimei Chen, Yungui Wang, Jie Jin, Hongyan Tong, Liangshun You, Hong-Hu Zhu

Get full text

Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival by Yi Liu, Xuejiao Yin, Shengnan Ding, Jiaying Ge, Liya Ma, Min Yang, Xuxia Luo, Chengli Zhong, Sishi Fang, Qiumei Yao, Li Zhu, Wenjuan Yu, Liping Mao, Juying Wei, Xingnong Ye, De Zhou, Hongyan Tong, Haitao Meng, Jie Jin, Liangshun You

Get full text